Provided by Tiger Trade Technology Pte. Ltd.

Hillhouse Capital Related

455.580
-14.279-3.04%
Number of Gainers:2
Number of Losers:46
Number of Flat:3
PE:- -
High:467.950
Open:467.950
Low:449.431
Close:469.859
Volume:208.14M
Turnover:6.45B
Market Cap:2.92T
Float Cap:2.00T

Loading ...

Meituan Stock Advances 1.1% in Hong Kong

Dow Jones
·
Sep 21

China Resources Beer (Holdings) Stock Climbs 1.4% in Hong Kong

Dow Jones
·
Sep 21

Haidilao International Holding Stock Advances 1.6% in Hong Kong

Dow Jones
·
Sep 21

Hansoh Pharmaceutical Group Stock Rises 3.7% in Hong Kong

Dow Jones
·
Sep 21

AH Premium Ranking Summary | September 21

Stock News
·
Sep 21

Antengene-B Surges Over 9% as Pivotal Phase III CLINCH-3 Trial Completes First Patient Dosing

Stock News
·
Sep 21

Citi Highlights Policy Boost for Innovative Drugs and Medical Devices, Names Key Sector Picks

Stock News
·
Sep 21

Innovative Drug Stocks Surge Across the Board in Morning Session, with Keymed Bio-B and Akeso Both Climbing Over 9%

Deep News
·
Sep 21

China's Roadmap for Pharmaceuticals May Support Sector Development

Dow Jones
·
Sep 21

Hansoh Rises on Positive Clinical Trial Results for Plaque Psoriasis Drug

Reuters
·
Sep 21

Genscript Biotech Surges 7% in Trading as JPMorgan Reaffirms Positive Stance

Deep News
·
Sep 21

Hong Kong Stock Market Flash | Genscript Biotech Surges Over 7% in Morning Session as AI Drug Discovery Models Reshape Its Business Trajectory

Stock News
·
Sep 21

Hong Kong Stocks Open Flat as Pharma Shares Lead Gains; Innovent Rises Nearly 2%

Stock News
·
Sep 21

Antengene Doses First Patient in Phase III Clinch-3 Trial of ATG-022 for Cldn18.2+ Gastric, GEJ Cancer

Reuters
·
Sep 21

Antengene Announces First Patient Dosed in Pivotal Phase Iii Clinch-3 Study of Atg-022

THOMSON REUTERS
·
Sep 21

Hansoh Pharma Says Phase 3 HS-10374 Psoriasis Trial Meets Co-Primary Endpoints

Reuters
·
Sep 21

Hansoh Pharmaceutical - Hs-10374 Meets Co-Primary Endpoints in Phase Iii Plaque Psoriasis Trial

THOMSON REUTERS
·
Sep 21

Key Platform Insights from Meituan | 2026 TravelDaily Summit

Deep News
·
Sep 20

Morgan Stanley Trims Stake in Genscript Biotech with HK$1.1 Billion Share Sale

Deep News
·
Sep 20

Beijing Regulators Launch Probes Into Major Online Travel Platforms, Companies Respond

Deep News
·
Sep 19